Autologous Adipose Cells Therapy

Launched by CERM INC. · Mar 4, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment called Autologous Adipose Cell Therapy, which aims to improve skin and hair conditions like wrinkles, fine lines, hair thinning, and skin texture. The goal is to see how safe and effective this therapy is for rejuvenating skin and enhancing hair growth compared to traditional methods. The trial is currently recruiting participants aged between 21 and 80 years who are experiencing issues like skin aging or hair loss and are interested in trying this new approach.

To join the trial, participants need to be in good health and provide a signed consent form. They should not be pregnant, have certain chronic diseases, or be taking hormone therapy. If eligible, participants will undergo a series of procedures and will be monitored throughout the study. This could be a great opportunity for those looking to improve their skin and hair appearance with a potentially innovative treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.
• • 2. Outpatients who are experiencing hair loss or hair thinning
• • 3. Provision of signed and dated informed consent form
• • 4. Clearly stated willingness to comply with all the procedures of the study and availability of the study
• • 5. Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor
• Exclusion Criteria:
• • 1. Pregnancy or lactation
• • 2. Known allergic reaction to components of cell culture media
• • 3. Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures
• • 4. Chronic infections, e.g. skin fungi infection, psoriasis
• • 5. Chronic wound healing
• • 6. Currently taking hormone therapy
• • 7. History of cancers and active cancers
• • 8. Viral infection, e.g. HIV, hepatitis B, influenza, coronaviruses.